A detailed history of Cibc Private Wealth Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 70 shares of RGEN stock, worth $8,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Holding current value
$8,385
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$170.78 - $208.42 $11,954 - $14,589
70 New
70 $12,000
Q3 2019

Oct 16, 2019

SELL
$76.65 - $95.51 $316,947 - $394,933
-4,135 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$54.2 - $85.95 $224,117 - $355,403
4,135 New
4,135 $355,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.65B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.